CIPLA Ltd Q1FY21 consolidated PAT up at Rs. 577.91 crore

CIPLA LTD. has reported financial results for the period ended June 30, 2020.

Financial Results (Q1 FY 2020-21) - QoQ Comparison

The company has reported total income of Rs.4411.61 crores during the period ended June 30, 2020 as compared to Rs.4469.37 crores during the period ended March 31, 2020.

The company has posted net profit / (loss) of Rs.577.91 crores for the period ended June 30, 2020 as against net profit / (loss) of Rs.245.95 crores for the period ended March 31, 2020.

The company has reported EPS of Rs.7.16 for the period ended June 30, 2020 as compared to Rs.3.05 for the period ended March 31, 2020.

Financials	Q1 FY2020-21	Q4 FY19-20	% Change
Total Income	₹ 4411.61 crs	₹ 4469.37 crs	-1.29%
Net Profit	₹ 577.91 crs	₹ 245.95 crs	134.97%
EPS	₹ 7.16	₹ 3.05	134.75%

Financial Results (Q1 FY 2020-21) - YoY Comparison

The company has reported total income of Rs.4411.61 crores during the period ended June 30, 2020 as compared to Rs.4067.39 crores during the period ended June 30, 2019.

The company has posted net profit / (loss) of Rs.577.91 crores for the period ended June 30, 2020 as against net profit / (loss) of Rs.478.19 crores for the period ended June 30, 2019.

The company has reported EPS of Rs.7.16 for the period ended June 30, 2020 as compared to Rs.5.93 for the period ended June 30, 2019.

Financials	Q1 FY2020-21	Q1 FY2019-20	% Change
Total Income	₹ 4411.61 crs	₹ 4067.39 crs	8.46%
Net Profit	₹ 577.91 crs	₹ 478.19 crs	20.85%
EPS	₹ 7.16	₹ 5.93	20.74%

Umang Vohra, MD and Global CEO, Cipla Ltd said, "Extremely pleased to report our Q1FY21 performance which reflects the inherent strength of our business backed by agile and resilient operations, cost control initiatives and continued delivery on our strategic priorities. During the quarter, our businesses actively re-imagined their operating models to drive strong growth across markets of India, South Africa, US and focused execution on cost optimization helped drive the quarter EBITDA to 24%. We are also at the forefront in combatting COVID-19 through our strategic partnerships and a spectrum of offerings in our portfolio. Through these challenging times, we stood by our commitment of enabling equitable access to promising treatments by launching a toll-free helpline to aid patients in procuring vital drugs across therapies. Our global lung leadership aspirations continued to gain momentum along with limited competition launches in the US".

Shares of CIPLA LTD. was last trading in BSE at Rs.728.6 as compared to the previous close of Rs. 731.7. The total number of shares traded during the day was 254886 in over 6363 trades.

The stock hit an intraday high of Rs. 739.6 and intraday low of 724.75. The net turnover during the day was Rs. 186248567.

Source : Equity Bulls

Keywords